Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
New research reveals how GLP-1 medications are reshaping the treatment landscape for conditions affecting the heart, kidney, liver, and more, hinting at a new era in chronic disease management
As a result of the ongoing COVID-19 pandemic, we have made changes to our patient care practices in accordance with all provincial and Public Health recommendations
Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
A., Lo, L
Dit fascinerende fenomeen, waarbij de emotionele en cognitieve systemen in ons lichaam in een staat van harmonie functioneren, biedt krachtige voordelen voor onze gezondheid
US$ 29.27
US$ 21.17
US$ 24.22
